China's Greater Bay Area opens first international clinical trial centre

Singapore, July 22 -- The Chinese University of Hong Kong (CUHK); the People's Government of Nansha District, Guangzhou; and Guangzhou First People's Hospital have signed an agreement to establish the... Read More

Monash University signs MoU with Therapeutic Goods Administration for pharma regulatory science

Singapore, July 22 -- Monash University has signed a Memorandum of Understanding (MoU) with Australia's Therapeutic Goods Administration (TGA), formally establishing collaboration in pharmaceutical re... Read More

Singapore-based biotech startup Tikva Allocell closes $8 M Series A funding round

Singapore, July 22 -- Tikva Allocell, a Singapore-based biotechnology startup developing engineered, allogeneic (donor-derived) cell therapies for adult and pediatric patients with solid tumours, has ... Read More

Australia injects $18 M into novel CAR-T cell therapy

Singapore, July 21 -- A "precision guided" CAR T-cell therapy designed at Peter MacCallum Cancer Centre, Australia's only public health service dedicated to caring for people affected by cancer, to ki... Read More

Singapore develops swallowable nanocage for targeted gastric cancer therapy

Singapore, July 21 -- Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have developed a swallowable nanoscale delivery platform designed to transp... Read More

Fangzhou launches Novo Nordisk's once-weekly basal insulin/GLP-1 therapy in China

Singapore, July 21 -- Fangzhou Inc. has announced the launch of Kyinsu(R), the world's first once-weekly basal insulin/GLP-1 RA combination therapy, on its Internet hospital platform, further expandin... Read More

Japanese startup Rege Nephro secures $10.6 M to expand kidney disease pipeline

Singapore, July 21 -- Rege Nephro, a clinical-stage biotechnology startup focused on induced pluripotent stem (iPS) cell-based kidney regenerative medicine and drug discovery, has announced the closin... Read More

Menarini and Pharmacosmos bring first-in-class oncology supportive care therapy Cosela(R) to Asia

Singapore, July 21 -- Menarini Asia-Pacific has announced an exclusive partnership with Pharmacosmos A/S to register, commercialise and distribute Cosela(R) (trilaciclib) across its Asia-Pacific marke... Read More

Korea's Samsung Biologics buys PolyPeptide for CHF 1.46 B

Singapore, July 20 -- South Korea-based Samsung Biologics has announced the launch of an all-cash public tender offer to acquire 100% of the fully diluted share capital of PolyPeptide Group AG, a lead... Read More

AstraZeneca inks $1.5 B deal with China's Dizal Pharma for novel oral EGFR inhibitor Zegfrovy for lung cancer

Singapore, July 20 -- AstraZeneca has entered into an exclusive license agreement with China-based Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel oral irreversible epidermal growth factor ... Read More

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»